Analytics & bioassays for biosimilars

Extensive bioanalytical and bioassay toolbox to ensure biosimilarity

We have an extensive analytical and bioassay toolbox that ensures biosimilarity, including in-depth analysis of post-translational modifications to match them to the originator. We also have access to a wide range of originator drugs to allow comparison.


We can establish and qualify physico-chemical and bioanalytical methods to fully characterize relevant target protein quality attributes, including in-depth analysis of post-translational modifications to match them to the originator.

  • Quantity & strength
    • Protein content (A280)
    • Titer (Octet, APAC)
  • Primary structure
    • Amino acid sequencing
    • Peptide map (RP-LC-MS)
  • Variants & glycans
    • Charge variants (HPC-CEX)
    • Site specific deaminication by peptide mapping (RP-LC-MS)
    • Site specific oxidication by peptide mapping (RP-LC-MS)
    • N-linked Glycans (HILIC-FLR/MS)
  • Aggregation & integrity
    • Dimers/aggregates (HPLC-SEC/MALS)
    • Fragments (CE-SDS)
  • Purity & stability
    • HCP (Elisa)
    • hcDNA (qPCR)
    • Residual protein A (ELISA)
    • Thermo stability (nano-DSF)
  • Safety
    • Bioburden
    • Endotoxin
    • Sterility
    • Mycoplasma


We have also developed a toolbox of bioassays especially designed for comparing biosimilar activity to originators. These include:

  • Binding (ELISA)
  • Cell based assays
  • Membrane bound antigen binding (FACS) on living cells
  • Classical ADCC assay using our proprietary affector cell line
  • CDC assay

Outlicesing and partnerships available

“We are committed to positive outcomes and delivering projects on time to specification”

Our analytical and bioassay services are designed to support our partners development projects to ensure the quality and purity of their therapeutics. However we will support any standalone project so we can accelerate your product to patients.

Contact us

Let’s collaborate and create quality biologics together.

Get in touch for more information.

We use cookies

Polpharma Biologics uses cookies and other similar technologies (hereinafter: cookies) on its webpages and mobile applications (hereinafter, jointly, Website). The user can manage cookies independently by changing the web browser settings. If you do not consent for your personal data to be collected via cookies, you should change your web browser settings or stop using the Website.

Using the Website without changing the web browser settings indicates your acceptance of the use of cookies by Polpharma. Acceptance of the web browser settings indicates your consent to profiling on the basis of the information contained in cookies. Consent may be withdrawn at any time. Withdrawal of consent does not affect lawfulness of any processing activities carried out under consent before its withdrawal.

For more details see the Cookie Policy.